Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
 | NOVO NORDISK | 5 | 40 | +0,23 % | |
| VESTAS WIND SYSTEMS | 3 | 9 | -1,25 % | |
| AP MOELLER-MAERSK | - | 23 | +0,18 % | |
| ORSTED | - | 17 | -0,28 % | |
| DANSKE BANK | - | 10 | +0,05 % | |
| BAVARIAN NORDIC | - | 7 | -0,48 % | |
| DSV | - | 4 | -0,22 % | |
| ROCKWOOL | - | 4 | -0,08 % | |
| CARLSBERG | - | 3 | 0,00 % | |
| JYSKE BANK | - | 3 | +0,17 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16:30 | Novo nordisk mit Rekordsignal: Analysten sehen massives Kurspotenzial - Positionieren Sie sich vor Börseneröffnung | Hebelschein-Spekulant | |||
| 09:50 | Samstag-Meldung zu NOVO NORDISK A/S: Jetzt kommt Bewegung! | 41 | Maximilian Berger | ||
| Fr | Lilly stock falls as Foundayo trails Novo's Wegovy in early uptake | 137 | iNVEZZ.com | ||
| Fr | NVO Reports Strong Phase III Diabetes Data for Children & Adolescents | 116 | Zacks | ||
| Fr | Aktien New York Ausblick: Nasdaq mit weiterer Rekordrally - Intel begeistert | 682 | dpa-AFX | NEW YORK (dpa-AFX) - Die Rekordrally der überwiegend mit Technologie-Aktien bestückten Nasdaq-Börse dürfte sich am Freitag fortsetzen. Durch KI getriebene starke Quartalszahlen und Ausblicke aus der... ► Artikel lesen | |
| Fr | Eli Lilly slips as obesity scripts said to trail those for Novo's Wegovy | 218 | Seeking Alpha | ||
| Fr | Danske Bank A/S, transactions by persons discharging managerial responsibilities | 3 | GlobeNewswire (USA) | ||
| Fr | Maersk and Altana agree to embed an AI-powered digital trade layer into the Gemini Cooperation | 4 | PortNews | ||
| Fr | Coloplast senkt die Prognose | 36 | ECOreporter | ||
| Fr | Royal UNIBREW A/S: Transactions by persons discharging managerial responsibilities and/or persons closely associated | 4 | GlobeNewswire (USA) | ||
| Fr | Vestas meldet Transaktionen im Zusammenhang mit dem Aktienrückkaufprogramm | 16 | Windkraft-Journal | ||
| Fr | Coloplast H1 Profit Before Special Items Rises; Revises FY Financial Guidance | 345 | AFX News | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Coloplast (COLO-B.CO, COLOb.CO) reported that its first half net profit before special items was 2.81 billion Danish kroner, a 6% increase from last year... ► Artikel lesen | |
| Do | Novo Nordisk (NVO) Sees a More Significant Dip Than Broader Market: Some Facts to Know | 77 | Zacks | ||
| Do | Coloplast A/S: Coloplast A/S - Coloplast revises financial guidance for FY 2025/26 to reflect reduced growth outlook for Kerecis | 120 | GlobeNewswire (Europe) | Announcement no. 04/2026Inside information Coloplast revises the financial guidance on organic growth and EBIT growth in constant currencies before special items for FY 2025/26, reflecting a slower... ► Artikel lesen | |
| Do | Coloplast A/S - Coloplast revises financial guidance for FY 2025/26 to reflect reduced growth outlook for Kerecis | 108 | GlobeNewswire (Europe) | Announcement no. 04/2026Inside information Coloplast revises the financial guidance on organic growth and EBIT growth in constant currencies before special items for FY 2025/26, reflecting a slower... ► Artikel lesen | |
| Do | Novo Nordisk Eyes Approval For Potential First Oral GLP-1 Diabetes Pill In Young Patients | 36 | Benzinga.com | ||
| Do | With trial win, Novo Nordisk eyes adolescent diabetes approval for oral semaglutide | 31 | FiercePharma | ||
| Do | Novo says oral semaglutide works in diabetic kids | 22 | pharmaphorum | ||
| Do | Is Novo Nordisk's 72% Crash a Generational Buying Opportunity or a Value Trap? | 70 | The Motley Fool | ||
| Do | Nach erfolgreichen Tests: Novo Nordisk will Diabetesmittel für Jugendliche auf den Markt bringen | 53 | n-tv.de |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.